Pomegra Wiki

PE Fund Investment Period: Suspension and Termination

A private equity fund’s investment period — the window in which the GP can call capital from LPs and deploy it in acquisitions — can end before its scheduled maturity if a key GP leaves, the GP is removed, or LPs vote to suspend. These triggers are written into the fund agreement and serve as LP protections against drift, loss of expertise, or GP misconduct. Understanding suspension mechanics is critical for fund investors and sponsors planning capital availability.

This article covers U.S.-domiciled private equity funds. Suspension and termination terms vary by fund agreement and jurisdiction. LPs should consult their fund documents and legal counsel for specific triggers.

The Investment Period: How Long Does a Fund Actually Invest?

A private equity fund is typically granted a stated investment period — usually 5 to 7 years — during which the general partner (GP) can call capital from limited partners (LPs) and deploy it in acquisitions. The investment period is distinct from the overall fund life, which may extend 10 to 12 years to allow for portfolio exits and distributions.

A fund agreement specifies:

  1. The stated investment period end date (e.g., June 2030 for a fund closed in 2024).
  2. Triggers that can shorten it (key-person departure, GP removal, LP supermajority vote).
  3. Consequences of suspension (GP loses call rights; fund enters harvest mode).

LPs want a defined investment window because it limits capital lockup. If a GP had unfettered rights to call capital indefinitely, an LP might face surprise capital calls years into the fund life, disrupting financial planning. The investment period creates a contractual endpoint, after which the fund focuses on managing and exiting existing portfolio positions.

Key-Person Events

A key-person clause names one or more individuals (typically the fund’s founder, managing partner, or lead sponsor) whose continued involvement is essential to fund strategy. If that person departs, dies, or becomes incapacitated, the clause is triggered.

Consequences of Key-Person Departure

When a key-person event occurs, the fund agreement typically allows a cure period — often 90 to 180 days — during which the GP must replace the departed partner with a substitute of comparable skill and institutional commitment. If no replacement is identified within this window, one of several outcomes applies:

  1. Automatic suspension: The investment period immediately terminates, and the fund transitions to portfolio management and exit.
  2. LP voting rights: LPs can vote to suspend, waive the key-person trigger, or allow the GP to continue with conditions.
  3. GP fallback: The GP must distribute remaining uncommitted capital to LPs and cease new commitments.

Strength of Key-Person Triggers

The teeth of a key-person clause depend on how concentrated expertise is perceived. In founder-led funds (e.g., the founder of a well-known firm creates a new fund), LPs view the founder’s presence as critical to strategy, deal sourcing, and portfolio oversight. The key-person clause will be tight: departure triggers immediate concern and likely suspension unless a strong successor is installed quickly.

In institutionalized funds (e.g., a multi-partner firm with deep bench strength), LPs may accept broader definitions or longer cure periods, because the fund has distribution of expertise across multiple partners.

Key-person clauses often include thresholds of seniority. A managing partner’s departure triggers the clause; a junior partner’s departure does not.

GP Removal for Cause

LPs have a contractual right to remove the GP for cause — typically defined as:

  • Material breach of the fund agreement (e.g., failure to disclose conflicts, misuse of assets, undisclosed fee-sharing).
  • Fraud or criminal conduct by the GP or its principals.
  • Gross negligence or willful misconduct in fund management.
  • Insolvency or bankruptcy of the GP.

Removal requires a supermajority vote of LPs — commonly 75% or higher. This threshold protects the GP from opportunistic minority coalitions and reflects the expectation that LPs will rarely resort to removal absent serious breach.

Process and Timeline

When a removal resolution is initiated:

  1. Notice and cure period: The GP is notified and given a period (often 30–60 days) to cure the alleged breach.
  2. LP vote: If the breach is not cured, LPs vote. Voting may occur via proxy or at a meeting, depending on the fund agreement.
  3. Effective date: If removal is approved, the GP typically must transfer fund assets to a successor GP or wind down the portfolio.

The successor GP is usually chosen by the LPs (often the largest or most involved LPs drive this), and they negotiate terms (whether the ousted GP retains a small carry or is fully displaced).

Outcomes After Removal

Once removed, the GP loses all call rights and management fees. The successor GP (or a GP-substitute) takes over portfolio and capital deployment. In some cases, the original fund’s remaining investment period is terminated entirely, and the fund transitions to harvest; in others, the successor may be granted a limited extension to deploy remaining capital.

LP Supermajority Vote to Suspend

Beyond key-person and for-cause removal, many funds grant LPs a direct right to suspend the investment period via supermajority vote. This is a blunt tool — it does not remove the GP, but it freezes all new capital calls and portfolio additions.

LPs might invoke this power if:

  • Fund performance is trailing benchmarks and LPs lose confidence in the GP’s ability to generate returns.
  • Strategy drift occurs (e.g., the fund advertises buyouts but is pursuing growth equity, a different risk profile).
  • Fee disputes arise (e.g., the GP is charging inflated transaction fees or management fees have exceeded contractual caps).
  • Governance breakdown (e.g., the GP’s board lacks independence or is dominated by insiders).
  • Market conditions deteriorate and LPs believe deploying more capital into the fund is imprudent.

The supermajority threshold for a voluntary suspension is typically 60–75% of LP capital, lower than removal thresholds because suspension is reversible and less drastic than displacing the GP.

Effects of Suspension

When the investment period is suspended (whether by key-person event, removal, or LP vote), the fund enters a harvest phase:

  • No new capital calls: The GP cannot make fresh capital calls to deploy in new acquisitions or add to existing positions.
  • Portfolio management: Existing holdings are actively managed (operational improvements, cost-cutting, revenue growth).
  • Exit execution: The GP focuses on liquidity events: secondary sales, M&A transactions, or IPOs.
  • Distributions to LPs: As exits close, proceeds flow back to LPs.

A suspended fund may run for many more years (often 3–5 additional years or longer) to complete portfolio exits. LPs remain locked in, but capital cannot be called for new investments.

Reinstatement and Amendment

Some fund agreements allow for reinstatement of the investment period if conditions change:

  • If a key-person gap is filled with a qualified replacement, LPs may vote to reinstate the investment period.
  • If an ousted GP is replaced with a new manager whom LPs trust, the new GP may receive call rights and a fresh investment window.

However, reinstatement is contractually discretionary and politically difficult. Once LPs have soured on a fund, they rarely give it a second chance at fresh capital.

Real-World Examples

Example 1: Founder Departure

A founder-led private equity firm closes a $500 million Fund IV in 2024. The fund agreement names the founder as the key person; his continued leadership is critical to LP confidence. In 2026, the founder unexpectedly departs to start a competing fund. The agreement triggers a 120-day cure period. If no replacement managing partner is identified and approved by LPs within 120 days, the fund’s investment period automatically suspends. The fund has deployed $200 million into 6 portfolio companies; the remaining $300 million is undeployed. After suspension, those $300 million remains undrawn, and the GP must manage the 6 existing holdings to exit. LPs are disappointed but retain residual value.

Example 2: LP Supermajority Action

A mid-market fund is tracking at 0.5x MOIC (multiple on invested capital) after three years of a planned five-year investment period. The fund has deployed 70% of its capital into five portfolio companies, most underperforming. A coalition of LPs representing 68% of capital votes to suspend the investment period, citing loss of confidence. The GP cannot call the remaining 30% ($75 million), and must focus on fixing existing holdings or selling them. The LPs hope to minimize further loss.

Suspension Frequency and LP Behavior

In practice, investment-period suspensions are uncommon. Well-established firms rarely lose key people or face removal, and LP supermajority suspensions are politically fraught (they trigger prolonged dispute and can end LP relationships). However, suspension clauses are standard in fund agreements as a structural safeguard. LPs view them as a backstop: if the GP drifts or crises occur, LPs have recourse.

GPs are highly motivated to prevent suspension, because it halts capital deployment and signals to the market that the fund is in trouble. This reputational damage can impair future fundraising.

See also

Wider context

  • Hedge fund — alternative fund structure with different suspension rules
  • Closed-end fund — listed funds with capital structures distinct from private equity
  • Limited partner — institutional investors in PE funds; drive governance
  • Due diligence — process LPs use to vet GPs before committing